Role of Inflammation in Psychiatric Disorders

被引:13
作者
Jeon, Sang Won [1 ]
Yoon, Ho-Kyoung [2 ]
Kim, Yong-Ku [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Psychiat, Kangbuk Samsung Hosp, 29,Saemunan Ro, Seoul 03181, South Korea
[2] Korea Univ, Coll Med, Dept Psychiat, Ansan Hosp, 123,Jeokgeum Ro, Ansan 15355, Gyeonggi Do, South Korea
来源
FRONTIERS IN PSYCHIATRY: ARTIFCIAL INTELLIGENCE, PRECISION MEDICINE, AND OTHER PARADIGM SHIFTS | 2019年 / 1192卷
关键词
Inflammation; Neuroinflammation; Cytokine; Psychiatric disorder; Depression; Medication; MAJOR DEPRESSION; INTERFERON-ALPHA; DOUBLE-BLIND; CYTOKINES; BRAIN; NEUROINFLAMMATION; CURCUMIN; SYSTEM; ACTIVATION; PAROXETINE;
D O I
10.1007/978-981-32-9721-0_24
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Psychiatric disorders are too multifactorial to be defined as a primarily-inflammatory disorder, and increased inflammatory response is not specific to mental disorder only. Numerous factors are involved in neuroinflammation, and there also are many confounding variables, making it difficult to obtain-consistent outcomes. Therefore, it is necessary to specify genetic, physiological, and epidemiological attributes of particular population groups vulnerable to inflammatory response as well as the disease subtypes. As of now, definitive inflammatory markers for psychiatric disorders have not been identified, but they could be very useful in patients with minimal vulnerability. In addition, it is possible to use inflammatory markers as depression biomarkers in subtypes of depression, which can serve as bases to develop medications to treat the disorder.
引用
收藏
页码:491 / 501
页数:11
相关论文
共 48 条
[1]   Cytokines, stress and depressive illness: brain-immune interactions [J].
Anisman, H ;
Merali, Z .
ANNALS OF MEDICINE, 2003, 35 (01) :2-11
[2]   Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness [J].
Berk, Michael ;
Dean, Olivia ;
Drexhage, Hemmo ;
McNeil, John J. ;
Moylan, Steven ;
O'Neil, Adrienne ;
Davey, Christopher G. ;
Sanna, Livia ;
Maes, Michael .
BMC MEDICINE, 2013, 11 :1-17
[3]   Blood levels of cytokines in elderly patients with major depressive disorder [J].
Brambilla, F ;
Maggioni, M .
ACTA PSYCHIATRICA SCANDINAVICA, 1998, 97 (04) :309-313
[4]   Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment [J].
Bull, S. J. ;
Huezo-Diaz, P. ;
Binder, E. B. ;
Cubells, J. F. ;
Ranjith, G. ;
Maddock, C. ;
Miyazaki, C. ;
Alexander, N. ;
Hotopf, M. ;
Cleare, A. J. ;
Norris, S. ;
Cassidy, E. ;
Aitchison, K. J. ;
Miller, A. H. ;
Pariante, C. M. .
MOLECULAR PSYCHIATRY, 2009, 14 (12) :1095-1104
[5]   The relationship between the fatty acid composition of immune cells and their function [J].
Calder, Philip C. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2008, 79 (3-5) :101-108
[6]   Neurobehavioral effects of interferon-α in cancer patients:: Phenomenology and paroxetine responsiveness of symptom dimensions [J].
Capuron, L ;
Gumnick, JF ;
Musselman, DL ;
Lawson, DH ;
Reemsnyder, A ;
Nemeroff, CB ;
Miller, AH .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (05) :643-652
[7]   A meta-analytic review of the impact of intranasal oxytocin administration on cortisol concentrations during laboratory tasks: Moderation by method and mental health [J].
Cardoso, Christopher ;
Kingdon, Danielle ;
Ellenbogen, Mark A. .
PSYCHONEUROENDOCRINOLOGY, 2014, 49 :161-170
[8]   A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase [J].
Christmas, David M. ;
Potokar, J. P. ;
Davies, Simon J. C. .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 :431-439
[9]   Questions raised by the cytokine hypothesis of depression [J].
de Beaurepaire, R .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (05) :610-617
[10]   Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder [J].
Dean, Brian ;
Tawadros, Nahed ;
Scarr, Elizabeth ;
Gibbons, Andrew S. .
JOURNAL OF AFFECTIVE DISORDERS, 2010, 120 (1-3) :245-248